Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Mar 24, 2020

Dr. Hartmut Ehrlich, CEO, Abivax  gives an update of the French biotech's phase-3 clinical trial drug candidate ABX464 which has shown impressive results.  Dr. Ehrlich discusses how this revolutionary small molecule for oral administration has shown strong anti-inflammatory effects to solve the unmet needs of patients...


Mar 24, 2020

Dr. Hartmut Ehrlich, CEO, Abivax  gives an update of the French biotech's phase-3 clinical trial drug candidate ABX464 which has shown impressive results.  Dr. Ehrlich discusses how this revolutionary small molecule for oral administration has shown strong anti-inflammatory effects to solve the unmet needs of patients...


Mar 23, 2020

Michelle Sexton Naturopathic Doctor is an assistant adjunct professor in the department of anesthesiology in the UCSD health system.  She also has a clinical naturopathic and holistic practice working with patients who are looking to understand the underlying cause of disease and to treat the cause rather than the...


Mar 23, 2020

Michelle Sexton Naturopathic Doctor is an assistant adjunct professor in the department of anesthesiology in the UCSD health system.  She also has a clinical naturopathic and holistic practice working with patients who are looking to understand the underlying cause of disease and to treat the cause rather than the...


Mar 19, 2020

Jeff Wolf, CEO, Heat Biologics describes the vaccine platform Heat has developed originally for oncology and their licensing agreement with the University of Miami to use the same vaccine approach for NIH-funded studies against Zika, malaria, and HIV against the Coronavirus.  Their novel approach is using allogeneic...